Literature DB >> 7522542

Two distinct deleted regions on the short arm of chromosome 1 in neuroblastoma.

G Schleiermacher1, M Peter, J Michon, J P Hugot, P Vielh, J M Zucker, H Magdelénat, G Thomas, O Delattre.   

Abstract

The short arm of chromosome 1p is the most frequently altered chromosome segment in neuroblastoma. The alterations, mainly deletions, are thought to be indicative of the presence of a tumor suppressor gene. To further refine the chromosome localization of this gene, we have studied paired constitutional and tumor DNA from a series of 60 patients with neuroblastoma at 2 minisatellite and 23 microsatellite loci dispersed along the short arm of chromosome 1. Twenty-two cases (37%) demonstrated loss of heterozygosity (LOH) at one or more loci on 1p. Surprisingly, the pattern of LOH enabled the identification of two distinct consensus regions of deletions. In agreement with previous reports, one region mapped to the distal short arm of chromosome 1. The other region was localized more proximally on 1p. Deletions observed in tumors involve either one or both of these regions. We show that the correlation between NMYC amplification and 1p deletion is limited to the deletions which involve the proximal region either alone or together with the distal region. These results suggest that two tumor suppressor genes on 1p might be involved in the development of neuroblastoma. Finally, we show that somatic mutations at microsatellite loci, frequently observed in other types of cancer, are rare events in neuroblastoma.

Entities:  

Mesh:

Year:  1994        PMID: 7522542     DOI: 10.1002/gcc.2870100409

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  23 in total

1.  Lack of homozygously inactivated p73 in single-copy MYCN primary neuroblastomas and neuroblastoma cell lines.

Authors:  X T Kong; V A Valentine; S T Rowe; M B Valentine; S T Ragsdale; B G Jones; D A Wilkinson; G M Brodeur; S L Cohn; A T Look
Journal:  Neoplasia       Date:  1999-04       Impact factor: 5.715

Review 2.  Clinical categories of neuroblastoma are associated with different patterns of loss of heterozygosity on chromosome arm 1p.

Authors:  J Mora; N K Cheung; B H Kushner; M P LaQuaglia; K Kramer; M Fazzari; G Heller; L Chen; W L Gerald
Journal:  J Mol Diagn       Date:  2000-02       Impact factor: 5.568

3.  Evidence for a rare prostate cancer-susceptibility locus at chromosome 1p36.

Authors:  M Gibbs; J L Stanford; R A McIndoe; G P Jarvik; S Kolb; E L Goode; L Chakrabarti; E F Schuster; V A Buckley; E L Miller; S Brandzel; S Li; L Hood; E A Ostrander
Journal:  Am J Hum Genet       Date:  1999-03       Impact factor: 11.025

Review 4.  Cytogenetic findings in a rare pediatric mixed glioneuronal tumor and review of the literature.

Authors:  Mariela C Coccé; Fabiana Lubieniecki; Marcelo Bartuluchi; Marta S Gallego
Journal:  Childs Nerv Syst       Date:  2009-04-22       Impact factor: 1.475

5.  Disseminated neuroblastomas under 1 year of age: cell biology and prognosis.

Authors:  F Lampert; H Christiansen; F Berner; H J Terpe; F Berthold
Journal:  J Neurooncol       Date:  1997-01       Impact factor: 4.130

6.  Search for neuroblastoma loci: characterization of tumor cell lines that could facilitate their positional cloning.

Authors:  M Romani; R Muresu; E V Volpi; C Rozzo; J M Marchi; I Casciano
Journal:  J Neurooncol       Date:  1997-01       Impact factor: 4.130

Review 7.  Neuroblastoma tumour genetics: clinical and biological aspects.

Authors:  N Bown
Journal:  J Clin Pathol       Date:  2001-12       Impact factor: 3.411

8.  Chromosome 1p and 19q deletions in malignant glioneuronal tumors with oligodendroglioma-like component.

Authors:  Hiroaki Takeuchi; Toshihiko Kubota; Ryuhei Kitai; Ken Matsuda; Norichika Hashimoto; Kazufumi Sato
Journal:  J Neurooncol       Date:  2008-09-10       Impact factor: 4.130

9.  Molecular cloning and characterization of human caspase-activated DNase.

Authors:  N Mukae; M Enari; H Sakahira; Y Fukuda; J Inazawa; H Toh; S Nagata
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

10.  The emerging molecular pathogenesis of neuroblastoma: implications for improved risk assessment and targeted therapy.

Authors:  Nadine Van Roy; Katleen De Preter; Jasmien Hoebeeck; Tom Van Maerken; Filip Pattyn; Pieter Mestdagh; Joëlle Vermeulen; Jo Vandesompele; Frank Speleman
Journal:  Genome Med       Date:  2009-07-27       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.